Skip to main content

UBS Group AG

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in RLMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,093,586
+$211,950 QoQ
Shares Held
158,033
+24.8% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. RLMD ranks #259 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,093,586 158,033
2026-03-31 $881,636 126,672
2025-12-31 $200,289 41,468
2025-09-30 $120,167 59,785
2025-06-30 $108,281 180,471
2025-03-31 $39,091 144,789
2024-12-31 $111,871 215,140
2024-09-30 $409,486 126,385
2024-06-30 $386,400 128,800
2024-03-31 $601,175 129,285
2023-12-31 $520,521 125,730
2023-09-30 $377,064 125,688
2023-06-30 $243,509 98,988
2023-03-31 $3,566 1,578
2022-12-31 $20,635 5,913
2022-09-30 $225,229 6,084
2022-06-30 $25,218 1,328
2022-03-31 $35,842 1,328
2021-12-31 $72,027 3,197
2021-09-30 $123,684 4,719
2021-06-30 $147,917 4,621
2021-03-31 $230,484 6,546
2020-12-31 $237,926 7,419
2020-09-30 $211,198 5,614
2020-06-30 $374,154 8,361
2020-03-31 $103,796 3,043